 Cytomegalovirus infections bone marrow transplant recipients intensive cytoreductive therapy Cytomegalovirus CMV infections bone marrow transplant recipients intensive cytoreductive therapy CMV excretion viremia seroconversion overall active infection CMV disease common Retinitis enteritis pneumonitis patients Allograft recipients likely CMV disease autograft patients comparable rates active CMV infection CMV disease rare primary infection autograft allograft recipients contrast CMV disease seropositive allograft recipients allograft recipients risk factors CMV pneumonitis seropositivity age years acute graft-vs.-host disease use cyclosporine prophylaxis graft-vs.-host disease protective active infection rates rates CMV pneumonitis allograft recipients successive years